Online first
Research paper
Published online: 2021-07-16

open access

Page views 1495
Article views/downloads 992
Get Citation

Connect on Social Media

Connect on Social Media

Endoglin promotes cell migration and invasion in endometriosis by regulating EMT

Xiutang Chen1, Junjian Wang2, Feixia Tu1, Qing Yang1, Dan Wang1, Qin Zhu1


Objectives: This study aims to investigate the expression and role of Endoglin (ENG) in endometriosis (EM).

Material and methods: In this study, quantitative real-time polymerase chain reaction, western blot and immunohistochemistry were used to examine the expression of ENG in tissues. Cellular experiments were performed to evaluate the effect of ENG on cellular biological function. Western blot was used to examine the expression of epithelial to mesenchymal transition-related proteins.

Results: The expression of ENG was significantly higher in the ectopic endometriotic tissues than that in eutopic endometriotic tissues. Knockdown of ENG inhibited cell viability, migration and invasion, and induced cell apoptosis in hEM15A cells. Additionally, silenced ENG caused increased levels of E-cadherin and decreased levels of N-cadherin, vimentin, MMP-2 and MMP-9.

Conclusions: These results confirmed that ENG may be involved in the development of endometriosis by promoting EMT process, revealing a new insight into the pathogenesis of endometriosis and contributing to the exploration of molecular therapeutic strategies against endometriosis.

Article available in PDF format

View PDF Download PDF file


  1. Falcone T, Flyckt R. Clinical management of endometriosis. Obstet Gynecol. 2018; 131(3): 557–571.
  2. Zhang Y, Qu P. Factors associated with ovarian endometriosis malignancy and its recurrence in Chinese women. J Obstet Gynaecol. 2019; 39(8): 1148–1153.
  3. Vercellini P, Buggio L, Berlanda N, et al. Estrogen-progestins and progestins for the management of endometriosis. Fertil Steril. 2016; 106(7): 1552–1571.e2.
  4. Tian H, Huang JJ, Golzio C, et al. Endoglin interacts with VEGFR2 to promote angiogenesis. FASEB J. 2018; 32(6): 2934–2949.
  5. Paauwe M, Heijkants RC, Oudt CH, et al. Endoglin targeting inhibits tumor angiogenesis and metastatic spread in breast cancer. Oncogene. 2016; 35(31): 4069–4079.
  6. Paauwe M, Schoonderwoerd MJA, Helderman RF, et al. Endoglin expression on cancer-associated fibroblasts regulates invasion and stimulates colorectal cancer metastasis. Clin Cancer Res. 2018; 24(24): 6331–6344.
  7. Kim SH, Choi YM, Chae HD, et al. Increased expression of endoglin in the eutopic endometrium of women with endometriosis. Fertil Steril. 2001; 76(5): 918–922.
  8. Harmsen MJ, Wong CFC, Mijatovic V, et al. Role of angiogenesis in adenomyosis-associated abnormal uterine bleeding and subfertility: a systematic review. Hum Reprod Update. 2019; 25(5): 647–671.
  9. Hirsch M, Begum MR, Paniz É, et al. Diagnosis and management of endometriosis: a systematic review of international and national guidelines. BJOG. 2018; 125(5): 556–564.
  10. Schoonderwoerd MJA, Koops MFM, Angela RA, et al. Targeting endoglin-expressing regulatory T cells in the tumor microenvironment enhances the effect of PD1 checkpoint inhibitor immunotherapy. Clin Cancer Res. 2020; 26(14): 3831–3842.
  11. Ollauri-Ibáñez C, Núñez-Gómez E, Egido-Turrión C, et al. Continuous endoglin (CD105) overexpression disrupts angiogenesis and facilitates tumor cell metastasis. Angiogenesis. 2020; 23(2): 231–247.
  12. Wang X, Zong L, Wang W, et al. CD105 overexpression mediates drug-resistance in choriocarcinoma cells through BMP9/Smad pathway. J Cancer. 2020; 11(2): 272–283.
  13. Bai S, Zhu W, Coffman L, et al. CD105 is expressed in ovarian cancer precursor lesions and is required for metastasis to the ovary. Cancers (Basel). 2019; 11(11): 1710.
  14. Hayrabedyan S, Kyurkchiev S, Kehayov I. FGF-1 and S100A13 possibly contribute to angiogenesis in endometriosis. J Reprod Immunol. 2005; 67(1–2): 87–101.
  15. Hayrabedyan S, Kyurkchiev S, Kehayov I. Endoglin (cd105) and S100A13 as markers of active angiogenesis in endometriosis. Reprod Biol. 2005; 5(1): 51–67.
  16. Mercado-Pimentel ME, Hubbard AD, Runyan RB. Endoglin and Alk5 regulate epithelial-mesenchymal transformation during cardiac valve formation. Dev Biol. 2007; 304(1): 420–432.
  17. Hu J, Guan W, Yan L, et al. Cancer stem cell marker endoglin (CD105) induces epithelial mesenchymal transition (EMT) but not metastasis in clear cell renal cell carcinoma. Stem Cells Int. 2019; 2019: 9060152.
  18. Du Y, Zhang Z, Xiong W, et al. Estradiol promotes EMT in endometriosis via MALAT1/miR200s sponge function. Reproduction. 2019; 157(2): 179–188.
  19. Xiong W, Zhang L, Liu H, et al. E -mediated EMT by activation of β-catenin/Snail signalling during the development of ovarian endometriosis. J Cell Mol Med. 2019; 23(12): 8035–8045.
  20. Proestling K, Birner P, Gamperl S, et al. Enhanced epithelial to mesenchymal transition (EMT) and upregulated MYC in ectopic lesions contribute independently to endometriosis. Reprod Biol Endocrinol. 2015; 13: 75.
  21. Bostanci Durmus A, Dincer Cengiz S, Yılmaz H, et al. The levels of matrix metalloproteinase-9 and neutrophil gelatinase-associated lipocalin in different stages of endometriosis. J Obstet Gynaecol. 2019; 39(7): 991–995.